Mindstrong's patented science and technology was developed by Dr. Dagum, and is based on four years of extensive clinical studies applying machine intelligence to human-computer interactions patterns. Mindstrong products are in clinical trials in numerous partnership projects with payers, providers, academics and the pharmaceutical industry to bring these new tools to bear on answering the most fundamental questions in behavioral health.
Market
Behavioral Health
Location
Palo Alto,
CA,
USA
Coinvestors
ARCH Venture Partners, Berggruen Holdings, Foresite Capital, One Mind Brain Health Impact Fund, Optum Ventures